- Home
- IPHA vs DOGZ Comparison
IPHA vs DOGZ Comparison
Compare IPHA & DOGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- DOGZ
- Stock Information
- Founded
- IPHA 1999
- DOGZ 2003
- Country
- IPHA France
- DOGZ China
- Employees
- IPHA N/A
- DOGZ N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- DOGZ Miscellaneous manufacturing industries
- Sector
- IPHA Health Care
- DOGZ Consumer Discretionary
- Exchange
- IPHA Nasdaq
- DOGZ Nasdaq
- Market Cap
- IPHA 160.1M
- DOGZ 165.1M
- IPO Year
- IPHA 2019
- DOGZ 2017
- Fundamental
- Price
- IPHA $2.18
- DOGZ $12.12
- Analyst Decision
- IPHA Hold
- DOGZ
- Analyst Count
- IPHA 2
- DOGZ 0
- Target Price
- IPHA $2.00
- DOGZ N/A
- AVG Volume (30 Days)
- IPHA 12.3K
- DOGZ 313.5K
- Earning Date
- IPHA 09-17-2025
- DOGZ 10-17-2025
- Dividend Yield
- IPHA N/A
- DOGZ N/A
- EPS Growth
- IPHA N/A
- DOGZ N/A
- EPS
- IPHA N/A
- DOGZ N/A
- Revenue
- IPHA $14,839,695.00
- DOGZ $20,707,707.00
- Revenue This Year
- IPHA $50.89
- DOGZ N/A
- Revenue Next Year
- IPHA N/A
- DOGZ N/A
- P/E Ratio
- IPHA N/A
- DOGZ N/A
- Revenue Growth
- IPHA N/A
- DOGZ 39.47
- 52 Week Low
- IPHA $1.29
- DOGZ $6.81
- 52 Week High
- IPHA $3.51
- DOGZ $58.50
- Technical
- Relative Strength Index (RSI)
- IPHA 60.94
- DOGZ 36.87
- Support Level
- IPHA $2.07
- DOGZ $11.11
- Resistance Level
- IPHA $2.28
- DOGZ $15.61
- Average True Range (ATR)
- IPHA 0.09
- DOGZ 0.87
- MACD
- IPHA 0.01
- DOGZ -0.25
- Stochastic Oscillator
- IPHA 69.70
- DOGZ 21.55
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About DOGZ Dogness (International) Corporation
Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.